Novo Nordisk Already Plans A 'Next Generation' Oral Semaglutide - CEO

 
• By Sten Stovall

Planned next generation of oral semaglutide 'is in the early research stage', Lars Fruergaard Jorgensen tells Scrip.

Anatomy
Oral Semaglutide Will Be Aimed At Diabetes, Obesity And Fatty Liver • Source: Shutterstock

More from Strategy

More from Business